EC Status and Availability


EC ever use among women of reproductive age: 0.3% (DHS 2007, among ever married women)*

EC knowledge among women of reproductive age: 11% (DHS 2012)

Contraceptive Use: 80.4% (DHS 2007, ever use of a modern method among ever married women)

Registered LNG-EC products:

Registered UPA-EC products:

  • ellaOne* - Available only with prescription

Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.

Where at least one type of ECP is available: Pharmacies, IPPF-affiliated system, Social marketing programs (eg PSI, DKT, MSI and PSIA)

Age restrictions for accessing ECPs: No data available

Legal/regulatory documents in which EC is included: No data available

Other relevant information: Indonesia's 2008 Essential Medicines List does not include EC.
*Ever Use of EC was not reported on in the 2012 DHS.

EC distributed via IPPF outlets (<500 in 2012).

In Indonesia, the lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is midwives, as of 2013. (USAID/DELIVER, Contraceptive Security Indicators, 2013)

In 2013, EC was not procured by the government (JSI/Deliver data).

For more information, see below:

Our country-by-country information comes from numerous sources, including partners from around the world. We have made every effort to ensure that the information included here is correct, but EC availability and policies can change quickly. We welcome your additions and/or corrections

To submit updates and corrections to ICEC, click here.

Begin a new search